No fees unless we win.
Get a free consultation
A December 2013 court order demanding that manufacturer Abbott Laboratories provide “long overdue” documents for Depakote is being viewed as a success for plaintiffs.
The court order, made in the US District Court for the Southern District of Illinois, ordered Abbott to turn over about 4,000 copies of documents relating to Depakote and birth defects “as soon as possible,” and to “exercise all avenues available.” The documents were originally supposed to be produced in April 2013.
Depacon, Depakote, Depakote CP, Depakote ER, Depakene or Stavzor have been linked to cognitive problems (such as decreased IQ scores, autism and Asperger’s syndrome) and physical birth defects (such as spina bifida, atrial septal defect, cleft palate, hypospadias, extra fingers or toes, and craniosynostosis) in babies exposed to valproate products during pregnancy.
In a safety communication dated 05/06/13, the U.S. Food and Drug Administration (FDA) advised health care professionals and women that the anti-seizure medication valproate sodium and related products are contraindicated and should not be taken by pregnant women for the prevention of migraine headaches. The FDA also raised the pregnancy category for valproate medicines used to prevent migraine headaches from category “D” (meaning that the potential benefit of the drug in pregnant women may be acceptable despite its potential risks) to “X” (the risk of use in pregnant women clearly outweighs any possible benefit of the drug).
If you used Depakote or a related drug during pregnancy and your child developed one of the cognitive problems or physical birth defects listed above, contact the Depakote attorneys of ZKB Law. You can call the firm toll free at (888) 841-9623 or submit a free case evaluation form found on our website.
Zoll & Kranz, LLC – Multidistrict Litigation Attorneys
Source: http://www.aboutlawsuits.com/wp-content/uploads/2013-12-13-Abbott-Order.pdf
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
